Clinical Trial Update: The Efficacy and Safety of Lcaritin Combined With Bevacizumab and FOLFIRI in Treatment of Liver Metastases From Colorectal Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating Lcaritin with Bevacizumab and FOLFIRI for liver metastases from colorectal cancer; efficacy and safety data not provided in snip…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• FOLFIRI (irinotecan, leucovorin, 5-fluorouracil)
• Lcaritin (Lcaritin)

Snippet

Sponsor: Sir Run Run Shaw Hospital | Conditions: Colorectal Cancer | Phase 4 | Status: UNKNOWN